Pricing Log in Create free account

Oruka Therapeutics, Inc. (ORKA) vs Rhythm Pharmaceuticals, Inc. (RYTM)

Oruka Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc. are both Biotechnology companies. Rhythm Pharmaceuticals, Inc. is the larger, with a market value of $7.3B against $6.4B — 1.1× the size. Oruka Therapeutics, Inc. has the higher net margin (0.00% vs −70.6%) and the lower return on invested capital (−40.2% vs 0.00%). Across the 13 metrics below, Oruka Therapeutics, Inc. leads on 10 and Rhythm Pharmaceuticals, Inc. on 3.

Valuation

Metric ORKA RYTM Biotechnology median
P/E n/m n/m 10.26
P/S n/m 25.49 9.18
P/B 5.47 81.36 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 24.35 8.98
Earnings yield (2.19%) (2.79%) (34.89%)
Free cash flow yield (1.66%) (1.78%) (24.52%)

Profitability

Metric ORKA RYTM Biotechnology median
Gross margin 0.00% 88.23% 65.16%
Operating margin 0.00% (66.70%) 0.00%
Net margin 0.00% (70.63%) 0.00%
Free cash flow margin 0.00% (29.13%) 0.00%
Return on equity (18.30%) (167.49%) (50.12%)
Return on assets (17.76%) (41.75%) (45.60%)
Return on invested capital (40.22%) 0.00% 0.00%

Growth

Metric ORKA RYTM Biotechnology median
Revenue growth (TTM) — 61.04% 6.26%
EPS growth (last fiscal year) 52.20% 28.34% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ORKA RYTM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 38.51 2.78 4.89
Net debt to EBITDA 2.65 2.04 1.01

Dividend

Metric ORKA RYTM Biotechnology median
Dividend yield 0.00% — 0.41%
Payout ratio — — —

Size

Metric ORKA RYTM Biotechnology median
Market cap 6.36b 7.28b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack